WHOLESALE PRODUCE SUPPLY LLC DBA Cut Fresh Fruit Mix recall — FDA H-0068-2026
Potential Listeria monocytogenes contamination.
Complete FDA and NHTSA recall records dated in 2025, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Potential Listeria monocytogenes contamination.
cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
Failed Impurities/Degradation Specifications
Failed Dissolution Specifications
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity,…
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength…
Product is missing the ingredient list (which lead to missing wheat and Yellow No. 6), and a nutritional panel.
Undeclared Yellow #5
Product label contains conflicting statements about inclusion and being free of Soy ingredient.
Undeclared Milk. During production the firm discovered that the ingredients "cheese and butter" is not listed in the ingredient statement and therefore the allergen milk was not listed in…
Potential yeast contamination.
Undeclared Yellow #5
Undeclared allergen (wheat).
Undeclared Yellow #5
Microbial contamination with Escherichia coli O7:K1 and E. Coli 1303.
Listeria monocytogenes. Recall was initiated after being notified by green onion supplier of a Listeria monocytogenes positive test result in the green onions which were used only in Ahi…
Undeclared Milk. During production the firm discovered that the ingredients "cheese and butter" is not listed in the ingredient statement and therefore the allergen milk was not listed in…
Shell egg product potentially contaminated with salmonella.
Lack of Assurance of Sterility
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk…
Lack of Assurance of Sterility
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.